What is he best known for?
The fields of study he is best known for:
Song Li mostly deals with Molecular biology, In vivo, Gene delivery, Cancer research and Genetic transfer.
His work deals with themes such as Cationic liposome, Hepatocyte nuclear factor 4, microRNA, Proinflammatory cytokine and Gene targeting, which intersect with Molecular biology.
His work in In vivo is not limited to one particular discipline; it also encompasses Pharmacology.
His work on Nanocarriers as part of general Pharmacology research is frequently linked to PEG ratio, thereby connecting diverse disciplines of science.
His work in Gene delivery tackles topics such as Liposome which are related to areas like Drug carrier.
His Cancer research research incorporates themes from Carcinogenesis, Immunology, Immune system, Receptor and CpG site.
His most cited work include:
- Nonviral gene therapy: promises and challenges. (518 citations)
- Hepatic Fatty Acid Transporter Cd36 Is a Common Target of LXR, PXR, and PPARγ in Promoting Steatosis (398 citations)
- Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery. (318 citations)
What are the main themes of his work throughout his whole career to date?
Song Li spends much of his time researching Cancer research, Pharmacology, In vivo, Molecular biology and Micelle.
His Cancer research study combines topics from a wide range of disciplines, such as Immunology, Cancer, Immune system, Immunotherapy and Cytotoxic T cell.
His Pharmacology study incorporates themes from Cancer cell, Biodistribution and Doxorubicin.
As a part of the same scientific family, he mostly works in the field of In vivo, focusing on Liposome and, on occasion, Gene delivery and DNA.
His Molecular biology research also works with subjects such as
- Genetic enhancement most often made with reference to Gene expression,
- Receptor and related Downregulation and upregulation, Liver X receptor and Cell biology.
His Micelle research is multidisciplinary, relying on both Combinatorial chemistry, Paclitaxel and Cytotoxicity.
He most often published in these fields:
- Cancer research (19.35%)
- Pharmacology (17.51%)
- In vivo (17.05%)
What were the highlights of his more recent work (between 2016-2021)?
- Cancer research (19.35%)
- Vitiligo (5.53%)
- Doxorubicin (9.22%)
In recent papers he was focusing on the following fields of study:
Cancer research, Vitiligo, Doxorubicin, In vivo and Oxidative stress are his primary areas of study.
His research in Cancer research intersects with topics in Cancer, Metastasis, Immune system, Immunotherapy and Combination therapy.
His Doxorubicin research incorporates elements of Micelle, Transfection, Prodrug, Pharmacology and Cytotoxicity.
His Transfection research is multidisciplinary, relying on both Nucleic acid and Genetic enhancement.
His Paclitaxel research extends to the thematically linked field of In vivo.
In his study, which falls under the umbrella issue of Nanocarriers, Liposome is strongly linked to Drug carrier.
Between 2016 and 2021, his most popular works were:
- lncRNA epigenetic landscape analysis identifies EPIC1 as an oncogenic lncRNA that interacts with MYC and promotes cell-cycle progression in cancer (214 citations)
- Doxorubicin delivered by a redox-responsive dasatinib-containing polymeric prodrug carrier for combination therapy. (57 citations)
- hTERT promotes the invasion of gastric cancer cells by enhancing FOXO3a ubiquitination and subsequent ITGB1 upregulation (45 citations)
In his most recent research, the most cited papers focused on:
His primary areas of investigation include Doxorubicin, Cancer research, Pharmacology, Prodrug and In vivo.
His Doxorubicin study combines topics in areas such as Cytotoxicity and Immunotherapy.
He has included themes like Cancer, Protein kinase B, In vitro, Mitochondrial ROS and Regulation of gene expression in his Cancer research study.
In the subject of general Pharmacology, his work in Drug is often linked to Total body irradiation, thereby combining diverse domains of study.
The In vivo study combines topics in areas such as Ethylene glycol, Biophysics and Nanocarriers.
His studies in Nanocarriers integrate themes in fields like Paclitaxel and Drug carrier.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
